Literature DB >> 15228584

Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.

Aleksandra J Isakovic1, N Joan Abbott, Zoran B Redzic.   

Abstract

The blood-brain barrier (BBB) efflux transport of [(14)C] adenosine was studied using the brain efflux index (BEI) technique. BEI increased linearly over the first 2 min after injection, with deviation from linearity thereafter; 90.12 +/- 1.5% of the injected [(14)C] radioactivity remained within the brain after 20 min. The remaining tracer appears to be mainly intracellular, trapped by phosphorylation, as an almost linear increase of BEI over 20 min was observed after intracerebral injection of [(14)C] adenosine together with 5-iodo tubercidin. The BBB efflux clearance of [(14)C] radioactivity was estimated to be 27.62 +/- 5.2 micro L/min/g, almost threefold higher than the BBB influx clearance estimated by the brain uptake index technique. High-performance liquid chromatography (HPLC) analysis of blood plasma collected from the jugular vein after the intracerebral injection revealed metabolic breakdown of [(14)C] adenosine into nucleobases. The BBB efflux transport was saturable with apparent K(m) = 13.22 +/- 1.75 micro m and V(max) = 621.07 +/- 71.22 pmole/min/g, which indicated that BBB efflux in vivo is 6.2-12p mole/min/g, negligible when compared to the reported rate of adenosine uptake into neurones/glia. However, these kinetic parameters also suggest that under conditions of elevated ISF adenosine in hypoxia/ischaemia, BBB efflux transport could increase up to 25% of the uptake into neurones/glia and become an important mechanism to oppose the rise in ISF concentration. HPLC-fluorometry detected 93.6 +/- 5.25 nm of adenosine in rat plasma, which is 17- to 220-fold lower than the reported K(m) of adenosine BBB influx in rat. Together with the observed rapid degradation inside endothelial cells, this indicated negligible BBB influx of intact adenosine under resting conditions. Cross-inhibition studies showed that unlabelled inosine, adenine and hypoxanthine caused a decrease in BBB efflux of [(14)C] radioactivity in a concentration-dependent manner, with K(i) of 16.7 +/- 4.88, 65.1 +/- 14.1 and 71.1 +/- 16.9 micro m, respectively. This could be due to either competition of unlabelled molecules with [(14)C] adenosine or competition with its metabolites hypoxanthine and adenine for the same transport sites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228584     DOI: 10.1111/j.1471-4159.2004.02439.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.

Authors:  Laura B Jaeger; William A Banks; Jozsef L Varga; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 2.  Inner blood-retinal barrier transporters: role of retinal drug delivery.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

3.  Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability.

Authors:  Ken-ichi Hosoya; Atsushi Yamamoto; Shin-ichi Akanuma; Masanori Tachikawa
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

4.  Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.

Authors:  Zoran Redzic
Journal:  Fluids Barriers CNS       Date:  2011-01-18

5.  Expression and functional activity of nucleoside transporters in human choroid plexus.

Authors:  Zoran B Redzic; Slava A Malatiali; Danica Grujicic; Aleksandra J Isakovic
Journal:  Cerebrospinal Fluid Res       Date:  2010-01-11

6.  Blood-brain barrier efflux transport of pyrimidine nucleosides and nucleobases in the rat.

Authors:  Zoran B Redzic; Slava A Malatiali; James D Craik; Miodrag L Rakic; Aleksandra J Isakovic
Journal:  Neurochem Res       Date:  2008-08-27       Impact factor: 3.996

Review 7.  Purines: From Diagnostic Biomarkers to Therapeutic Agents in Brain Injury.

Authors:  Bruno G Frenguelli; Nicholas Dale
Journal:  Neurosci Bull       Date:  2020-06-15       Impact factor: 5.203

8.  Uneven distribution of nucleoside transporters and intracellular enzymatic degradation prevent transport of intact [14C] adenosine across the sheep choroid plexus epithelium as a monolayer in primary culture.

Authors:  Zoran B Redzic; Aleksandra J Isakovic; Sonja T Misirlic Dencic; Dusan Popadic; Malcolm B Segal
Journal:  Cerebrospinal Fluid Res       Date:  2006-03-29

9.  Oral administration of inosine produces antidepressant-like effects in mice.

Authors:  Junko Muto; Hosung Lee; Hyunjin Lee; Akemi Uwaya; Jonghyuk Park; Sanae Nakajima; Kazufumi Nagata; Makoto Ohno; Ikuroh Ohsawa; Toshio Mikami
Journal:  Sci Rep       Date:  2014-02-26       Impact factor: 4.379

10.  Effects of selective carotid body stimulation with adenosine in conscious humans.

Authors:  Stanislaw Tubek; Piotr Niewinski; Krzysztof Reczuch; Dariusz Janczak; Artur Rucinski; Bartlomiej Paleczny; Zoar J Engelman; Waldemar Banasiak; Julian F R Paton; Piotr Ponikowski
Journal:  J Physiol       Date:  2016-09-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.